Advances in the treatment of infantile hemangiomas of the larynx.
10.13201/j.issn.2096-7993.2023.12.009
- Author:
Xing GAO
1
;
Xiaojun ZHAN
1
;
Qinglong GU
1
Author Information
1. Department of Otolaryngology Head and Neck Surgery，Children's Hospital，Capital Institute of Pediatrics，Beijing，100020，China.
- Publication Type:Journal Article
- Keywords:
infantile hemangiomas;
injection sclerotherapy;
subglottic hemangioma;
β-blocker
- MeSH:
Child, Preschool;
Humans;
Infant;
Infant, Newborn;
Hemangioma/diagnosis*;
Hemangioma, Capillary;
Laryngeal Neoplasms/surgery*;
Larynx/pathology*;
Soft Tissue Neoplasms
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2023;37(12):972-976
- CountryChina
- Language:Chinese
-
Abstract:
Infantile hemangiomas are relatively common soft tissue tumors in infants and young children, with a prevalence of about 4.5% in full-term newborns. Subglottic Hemangioma （SGH） is a relatively rare type of hemangioma, and its special location often causes respiratory distress and potentially life-threatening conditions in infants. Therefore, it is necessary for clinicians to make an accurate diagnosis and formulate a detailed treatment plan based on the clinical manifestations, the auxiliary examinations, the medical history and the vital signs evaluation of patients.This review describes the pathophysiological mechanism of infantile hemangioma and provides a detailed discussion on commonly used treatment methods in detail.
